{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:46:34Z","timestamp":1768437994332,"version":"3.49.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH104086"],"award-info":[{"award-number":["R01MH104086"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10461-021-03188-x","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T19:02:31Z","timestamp":1617390151000},"page":"3159-3171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["START (Supporting Treatment Adherence Readiness through Training) Improves Both HIV Antiretroviral Adherence and Viral Reduction, and is Cost Effective: Results of a Multi-site Randomized Controlled Trial"],"prefix":"10.1007","volume":"25","author":[{"given":"Glenn J.","family":"Wagner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Linnemayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachana","family":"Seelam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Ghosh-Dastidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"3188_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-153","author":"E Foca","year":"2014","unstructured":"Foca E, et al. Clinical and immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa. Bmc Infect Dis. 2014. https:\/\/doi.org\/10.1186\/1471-2334-14-153.","journal-title":"Bmc Infect Dis"},{"issue":"11","key":"3188_CR2","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/QAD.0b013e328354bed6","volume":"26","author":"BL Genberg","year":"2012","unstructured":"Genberg BL, et al. Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America. Aids. 2012;26(11):1415\u201323.","journal-title":"Aids"},{"issue":"2","key":"3188_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/QAD.0b013e32834e9d7d","volume":"26","author":"JZ Li","year":"2012","unstructured":"Li JZ, et al. Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure. Aids. 2012;26(2):185\u201392.","journal-title":"Aids"},{"issue":"5","key":"3188_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s40265-015-0373-2","volume":"75","author":"CW Holtzman","year":"2015","unstructured":"Holtzman CW, Brady KA, Yehia BR. Retention in care and medication adherence: current challenges to antiretroviral therapy success. Drugs. 2015;75(5):445\u201354.","journal-title":"Drugs"},{"issue":"3","key":"3188_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/QAI.0000000000002142","volume":"82","author":"KK Byrd","year":"2019","unstructured":"Byrd KK, et al. Antiretroviral adherence level necessary for HIV viral suppression using real-world data. J Acquir Immune Defic Syndr. 2019;82(3):245\u201351.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"3188_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1345\/aph.1P587","volume":"45","author":"AB Kobin","year":"2011","unstructured":"Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. Ann Pharmacother. 2011;45(3):372\u20139.","journal-title":"Ann Pharmacother"},{"issue":"8","key":"3188_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1086\/651419","volume":"50","author":"JJ Parienti","year":"2010","unstructured":"Parienti JJ, et al. Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. Clin Infect Dis. 2010;50(8):1192\u20137.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"3188_CR8","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/infdis\/jis502","volume":"206","author":"AO Pasternak","year":"2012","unstructured":"Pasternak AO, et al. Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis. 2012;206(9):1443\u201352.","journal-title":"J Infect Dis"},{"key":"3188_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2147\/PPA.S192735","volume":"13","author":"F Altice","year":"2019","unstructured":"Altice F, et al. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adherence. 2019;13:475\u201390.","journal-title":"Patient Prefer Adherence"},{"issue":"9","key":"3188_CR10","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/cid\/ciu046","volume":"58","author":"JB Nachega","year":"2014","unstructured":"Nachega JB, et al. Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials. Clin Infect Dis. 2014;58(9):1297\u2013307.","journal-title":"Clin Infect Dis"},{"issue":"42","key":"3188_CR11","doi-asserted-by":"publisher","first-page":"e1677","DOI":"10.1097\/MD.0000000000001677","volume":"94","author":"PG Clay","year":"2015","unstructured":"Clay PG, et al. Meta-analysis of studies comparing single and multi-tablet fixed dose combination HIV treatment regimens. Medicine (Baltimore). 2015;94(42):e1677.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"3188_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/cid\/ciq243","volume":"52","author":"EM Gardner","year":"2011","unstructured":"Gardner EM, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793\u2013800.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3188_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s10461-011-9942-x","volume":"15","author":"C Ortego","year":"2011","unstructured":"Ortego C, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011;15(7):1381\u201396.","journal-title":"AIDS Behav"},{"issue":"2","key":"3188_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/1545109711420498","volume":"11","author":"J Shuter","year":"2012","unstructured":"Shuter J, et al. Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults. J Int Assoc Phys AIDS Care (Chic). 2012;11(2):94\u20137.","journal-title":"J Int Assoc Phys AIDS Care (Chic)"},{"issue":"1","key":"3188_CR15","doi-asserted-by":"publisher","first-page":"e0170893","DOI":"10.1371\/journal.pone.0170893","volume":"12","author":"JY Fonsah","year":"2017","unstructured":"Fonsah JY, et al. Adherence to antiretroviral therapy (ART) in Yaound\u00e9-Cameroon: Association with opportunistic infections, depression, ART regimen and side Effects. PLoS ONE. 2017;12(1):e0170893.","journal-title":"PLoS ONE"},{"issue":"12","key":"3188_CR16","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1080\/09540121.2018.1503637","volume":"30","author":"K Brittain","year":"2018","unstructured":"Brittain K, et al. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa. AIDS Care. 2018;30(12):1517\u201323.","journal-title":"AIDS Care"},{"issue":"4","key":"3188_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013;39(4):633\u201345.","journal-title":"Immunity"},{"issue":"3","key":"3188_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.qai.0000197870.99196.ea","volume":"41","author":"KR Amico","year":"2006","unstructured":"Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions\u2014a research synthesis of trials, 1996 to 2004. Jaids J Acquire Immune Defic Syndr. 2006;41(3):285\u201397.","journal-title":"Jaids J Acquire Immune Defic Syndr"},{"issue":"10","key":"3188_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/hiv.12051","volume":"14","author":"T Mathes","year":"2013","unstructured":"Mathes T, et al. Adherence-enhancing interventions for highly active antiretroviral therapy in HIV-infected patients\u2014a systematic review. HIV Med. 2013;14(10):583\u201395.","journal-title":"HIV Med"},{"issue":"1","key":"3188_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11904-009-0037-5","volume":"7","author":"JM Simoni","year":"2010","unstructured":"Simoni JM, et al. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV\/AIDS Rep. 2010;7(1):44\u201351.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"3188_CR21","doi-asserted-by":"publisher","first-page":"e0189770","DOI":"10.1371\/journal.pone.0189770","volume":"13","author":"K Ridgeway","year":"2018","unstructured":"Ridgeway K, et al. Interventions to improve antiretroviral therapy adherence among adolescents in low- and middle-income countries: a systematic review of the literature. PLoS ONE. 2018;13(1):e0189770.","journal-title":"PLoS ONE"},{"issue":"1S","key":"3188_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1037\/0278-6133.19.Suppl1.57","volume":"19","author":"ME Bouton","year":"2000","unstructured":"Bouton ME. A learning theory perspective on lapse, relapse, and the maintenance of behavior change. Health Psychol. 2000;19(1S):57\u201363.","journal-title":"Health Psychol"},{"key":"3188_CR23","volume-title":"Relapse prevention: maintenance strategies in the treatment of addictive behaviors","author":"GA Marlatt","year":"2005","unstructured":"Marlatt GA, Donovan DM. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. 2nd ed. New York: The Guilford Press; 2005.","edition":"2"},{"issue":"5","key":"3188_CR24","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/QAI.0000000000000025","volume":"64","author":"IB Wilson","year":"2013","unstructured":"Wilson IB, et al. Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results From the Multisite Adherence Collaboration on HIV 14 study. Jaids J Acquir Immune Defic Syndr. 2013;64(5):448\u201354.","journal-title":"Jaids J Acquir Immune Defic Syndr"},{"issue":"3","key":"3188_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/QAI.0000000000001909","volume":"80","author":"TK Phillips","year":"2019","unstructured":"Phillips TK, et al. Decreases in self-reported ART adherence predict HIV viremia among pregnant and postpartum South African women. J Acquir Immune Defic Syndr. 2019;80(3):247\u201354.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"sup5","key":"3188_CR26","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1080\/09540121.2018.1510107","volume":"30","author":"A Musiimenta","year":"2018","unstructured":"Musiimenta A, et al. Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda. AIDS Care. 2018;30(sup5):S89-s96.","journal-title":"AIDS Care"},{"issue":"2","key":"3188_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1545109712459041","volume":"12","author":"KR Amico","year":"2013","unstructured":"Amico KR, Orrell C. Antiretroviral therapy adherence support: recommendations and future directions. J Int Assoc Provid AIDS Care. 2013;12(2):128\u201337.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"2","key":"3188_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1037\/0278-6133.15.2.114","volume":"15","author":"JD Fisher","year":"1996","unstructured":"Fisher JD, et al. Changing AIDS risk behavior: effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population. Health Psychol. 1996;15(2):114\u201323.","journal-title":"Health Psychol"},{"issue":"9","key":"3188_CR29","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1007\/s10461-013-0550-9","volume":"17","author":"GJ Wagner","year":"2013","unstructured":"Wagner GJ, Lovely P, Schneider S. Pilot controlled trial of the adherence readiness program: an intervention to assess and sustain HIV antiretroviral adherence readiness. AIDS Behav. 2013;17(9):3059\u201365.","journal-title":"AIDS Behav"},{"key":"3188_CR30","volume-title":"Motivational interviewing: preparing people to change","author":"WR Miller","year":"2002","unstructured":"Miller WR, Rollnick S. Motivational interviewing: preparing people to change. New York: Guilford Press; 2002."},{"key":"3188_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13063-016-1287-3","volume":"17","author":"GJ Wagner","year":"2016","unstructured":"Wagner GJ, et al. Supporting Treatment Adherence Readiness through Training (START) for patients with HIV on antiretroviral therapy: study protocol for a randomized controlled trial. Trials. 2016;17:162.","journal-title":"Trials"},{"issue":"4","key":"3188_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00002030-200003100-00008","volume":"14","author":"DR Bangsberg","year":"2000","unstructured":"Bangsberg DR, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357\u201366.","journal-title":"AIDS"},{"key":"3188_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical analysis with missing data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. New York: John Wiley & Sons Inc.; 2002.","edition":"2"},{"issue":"3","key":"3188_CR34","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2307\/2344614","volume":"135","author":"JA Nelder","year":"1972","unstructured":"Nelder JA, Wedderburn RWM. Generalized linear models. J R Stat Soc Ser A. 1972;135(3):370\u201384.","journal-title":"J R Stat Soc Ser A"},{"key":"3188_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/CLEP.S129785","volume":"9","author":"AB Pedersen","year":"2017","unstructured":"Pedersen AB, et al. Missing data and multiple imputation in clinical epidemiological research. Clin Epidemiol. 2017;9:157\u201366.","journal-title":"Clin Epidemiol"},{"key":"3188_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons Inc.; 1987."},{"key":"3188_CR37","doi-asserted-by":"publisher","DOI":"10.1201\/9781439821862","volume-title":"Analysis of Incomplete Multivariate Data","author":"JL Schafer","year":"1997","unstructured":"Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman & Hall; 1997."},{"issue":"9385","key":"3188_CR38","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(03)14229-8","volume":"362","author":"G Ch\u00eane","year":"2003","unstructured":"Ch\u00eane G, et al. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet. 2003;362(9385):679\u201386.","journal-title":"Lancet"},{"issue":"5","key":"3188_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1001\/jama.2018.21167","volume":"321","author":"RW Eisinger","year":"2019","unstructured":"Eisinger RW, Dieffenbach CW, Fauci AS. HIV viral load and transmissibility of HIV infection: undetectable equals untransmittable. JAMA. 2019;321(5):451\u20132.","journal-title":"JAMA"},{"issue":"1","key":"3188_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1086\/498515","volume":"42","author":"N Lohse","year":"2006","unstructured":"Lohse N, et al. Virological control during the first 6\u201318 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study. Clin Infect Dis. 2006;42(1):136\u201344.","journal-title":"Clin Infect Dis"},{"key":"3188_CR41","unstructured":"County of Los Angeles Public Health, Los Angeles County HIV-AIDS strategy for 2020 and beyond. 2018."},{"issue":"9","key":"3188_CR42","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","volume":"15","author":"DR Bangsberg","year":"2001","unstructured":"Bangsberg DR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. Aids. 2001;15(9):1181\u20133.","journal-title":"Aids"},{"issue":"8","key":"3188_CR43","doi-asserted-by":"publisher","first-page":"564","DOI":"10.7326\/0003-4819-146-8-200704170-00007","volume":"146","author":"JB Nachega","year":"2007","unstructured":"Nachega JB, et al. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146(8):564\u201373.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3188_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/01.aids.0000168975.44219.45","volume":"19","author":"RH Remien","year":"2005","unstructured":"Remien RH, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. Aids. 2005;19(8):807\u201314.","journal-title":"Aids"},{"key":"3188_CR45","unstructured":"Center for Disease Control and Prevention, Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 U.S. dependent areas. 2019."},{"issue":"1","key":"3188_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/apc.2008.0132","volume":"23","author":"KB Ulett","year":"2009","unstructured":"Ulett KB, et al. The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care STDS. 2009;23(1):41\u20139.","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"3188_CR47","first-page":"12","volume":"19","author":"TP Giordano","year":"2011","unstructured":"Giordano TP. Retention in HIV care: what the clinician needs to know. Top Antivir Med. 2011;19(1):12\u20136.","journal-title":"Top Antivir Med"},{"issue":"2","key":"3188_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1086\/595705","volume":"48","author":"MJ Mugavero","year":"2009","unstructured":"Mugavero MJ, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clin Infect Dis. 2009;48(2):248\u201356.","journal-title":"Clin Infect Dis"},{"key":"3188_CR49","unstructured":"Department of Health and Human Services. Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. 2020; Available from: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf."},{"key":"3188_CR50","unstructured":"Gordon, K., et al., Examining correlates of pre-ART and early ART adherence to identify key factors influencing adherence readiness. Aids and Behavior, In ess."},{"issue":"1","key":"3188_CR51","doi-asserted-by":"publisher","first-page":"e000159","DOI":"10.1136\/bmjresp-2016-000159","volume":"3","author":"S Howard","year":"2016","unstructured":"Howard S, et al. What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective. BMJ Open Respir Res. 2016;3(1):e000159.","journal-title":"BMJ Open Respir Res"},{"issue":"8","key":"3188_CR52","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.amjmed.2003.07.007","volume":"115","author":"SJ Goldie","year":"2003","unstructured":"Goldie SJ, et al. Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection. Am J Med. 2003;115(8):632\u201341.","journal-title":"Am J Med"},{"issue":"4","key":"3188_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamainternmed.2013.2152","volume":"173","author":"R Gross","year":"2013","unstructured":"Gross R, et al. Managed problem solving for antiretroviral therapy adherence: a randomized trial. JAMA Intern Med. 2013;173(4):300\u20136.","journal-title":"JAMA Intern Med"},{"issue":"Suppl 1","key":"3188_CR54","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.1097\/01.qai.0000248334.52072.25","volume":"43","author":"KA Freedberg","year":"2006","unstructured":"Freedberg KA, et al. Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S113-8.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03188-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-021-03188-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-021-03188-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T21:27:44Z","timestamp":1630704464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-021-03188-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["3188"],"URL":"https:\/\/doi.org\/10.1007\/s10461-021-03188-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"4 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the UCLA institutional review board. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}